Advances in Cell Transplantation Therapy for Limbal Stem Cell Deficiency.

IF 2.1 4区 医学 Q4 CELL & TISSUE ENGINEERING Current stem cell research & therapy Pub Date : 2024-01-01 DOI:10.2174/1574888X18666230821102450
Yujia Gui, Yuxi He, Di Wang, Shurong Wang, Yan Zhang
{"title":"Advances in Cell Transplantation Therapy for Limbal Stem Cell Deficiency.","authors":"Yujia Gui, Yuxi He, Di Wang, Shurong Wang, Yan Zhang","doi":"10.2174/1574888X18666230821102450","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Limbal stem cells (LSCs) are essential for maintaining corneal transparency and ocular surface integrity. Many external factors or genetic diseases can lead to corneal limbal stem cell deficiency (LSCD), resulting in the loss of barrier and corneal epithelial cell renewal functions. Stem cell transplantation is one of the primary treatments for LSCD, including limbal transplantation and cultivated limbal epithelial transplantation. In addition, a variety of non-limbal stem cell lines have been experimented with for LSCD treatment. Biological scaffolds are also used to support <i>in vitro</i> stem cell culture and transplantation. Here, we review the mechanisms of corneal maintenance by LSCs, the clinical stage and surgical treatment of LSCD, the source of stem cells, and the biological scaffolds required for <i>in vitro</i> culture.</p><p><strong>Methods: </strong>This study is a narrative retrospective study aimed at collecting available information on various aspects of surgical treatments for LSCD. Relevant literature was searched in a range of online databases, including Web of Science, Scopus, and PubMed from 2005 to March, 2023.</p><p><strong>Results: </strong>A total of 397 relevant articles were found, and 49 articles with strong relevance to the studies in this paper were obtained and analyzed. Moreover, 11 of these articles were on the concept of LSCD and the mechanism of LESCs maintaining the corneal epithelium, 3 articles on the staging and grading of LSCD, 17 articles on cell transplantation methods and donor cell sources, and 18 articles on scaffolds for delivering stem cells. We also summarized the advantages and disadvantages of different cell transplantation methods and the benefits and limitations of scaffolds based on the above literature.</p><p><strong>Conclusion: </strong>The treatment of LSCD is determined by the clinical stage and whether it involves monocular or binocular eyes. Appropriate surgical techniques should be taken for LSCD patients in order to reconstruct the ocular surface, relieve symptoms, and restore visual function. Meanwhile, biological scaffolds assist in the <i>ex vivo</i> culture and implantation of stem cells.</p>","PeriodicalId":10979,"journal":{"name":"Current stem cell research & therapy","volume":" ","pages":"933-941"},"PeriodicalIF":2.1000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current stem cell research & therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/1574888X18666230821102450","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Limbal stem cells (LSCs) are essential for maintaining corneal transparency and ocular surface integrity. Many external factors or genetic diseases can lead to corneal limbal stem cell deficiency (LSCD), resulting in the loss of barrier and corneal epithelial cell renewal functions. Stem cell transplantation is one of the primary treatments for LSCD, including limbal transplantation and cultivated limbal epithelial transplantation. In addition, a variety of non-limbal stem cell lines have been experimented with for LSCD treatment. Biological scaffolds are also used to support in vitro stem cell culture and transplantation. Here, we review the mechanisms of corneal maintenance by LSCs, the clinical stage and surgical treatment of LSCD, the source of stem cells, and the biological scaffolds required for in vitro culture.

Methods: This study is a narrative retrospective study aimed at collecting available information on various aspects of surgical treatments for LSCD. Relevant literature was searched in a range of online databases, including Web of Science, Scopus, and PubMed from 2005 to March, 2023.

Results: A total of 397 relevant articles were found, and 49 articles with strong relevance to the studies in this paper were obtained and analyzed. Moreover, 11 of these articles were on the concept of LSCD and the mechanism of LESCs maintaining the corneal epithelium, 3 articles on the staging and grading of LSCD, 17 articles on cell transplantation methods and donor cell sources, and 18 articles on scaffolds for delivering stem cells. We also summarized the advantages and disadvantages of different cell transplantation methods and the benefits and limitations of scaffolds based on the above literature.

Conclusion: The treatment of LSCD is determined by the clinical stage and whether it involves monocular or binocular eyes. Appropriate surgical techniques should be taken for LSCD patients in order to reconstruct the ocular surface, relieve symptoms, and restore visual function. Meanwhile, biological scaffolds assist in the ex vivo culture and implantation of stem cells.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
细胞移植治疗肢端干细胞缺乏症的进展。
背景:角膜缘干细胞对维持角膜透明度和眼表完整性至关重要。许多外部因素或遗传疾病都可能导致角膜缘干细胞缺乏症(LSCD),导致角膜屏障和角膜上皮细胞更新功能丧失。干细胞移植是治疗 LSCD 的主要方法之一,包括角膜缘移植和培养角膜缘上皮移植。此外,各种非角膜缘干细胞系也被用于治疗 LSCD。生物支架也被用于支持体外干细胞培养和移植。在此,我们回顾了LSCs维护角膜的机制、LSCD的临床阶段和手术治疗、干细胞来源以及体外培养所需的生物支架:本研究是一项叙事性回顾研究,旨在收集有关 LSCD 手术治疗各方面的现有信息。从 2005 年到 2023 年 3 月,在一系列在线数据库(包括 Web of Science、Scopus 和 PubMed)中检索了相关文献:结果:共找到 397 篇相关文章,其中 49 篇与本文研究密切相关,并对其进行了分析。此外,其中11篇文章涉及LSCD的概念和LESCs维持角膜上皮的机制,3篇文章涉及LSCD的分期和分级,17篇文章涉及细胞移植方法和供体细胞来源,18篇文章涉及输送干细胞的支架。我们还根据上述文献总结了不同细胞移植方法的优缺点以及支架的优点和局限性:结论:LSCD的治疗方法取决于临床分期以及是单眼还是双眼。对 LSCD 患者应采取适当的手术技术,以重建眼表,缓解症状,恢复视功能。同时,生物支架有助于干细胞的体外培养和植入。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Current stem cell research & therapy
Current stem cell research & therapy CELL & TISSUE ENGINEERING-CELL BIOLOGY
CiteScore
4.20
自引率
3.70%
发文量
197
审稿时长
>12 weeks
期刊介绍: Current Stem Cell Research & Therapy publishes high quality frontier reviews, drug clinical trial studies and guest edited issues on all aspects of basic research on stem cells and their uses in clinical therapy. The journal is essential reading for all researchers and clinicians involved in stem cells research.
期刊最新文献
Deciphering the Immunomodulatory Pathways of Mesenchymal Stem Cells Insights into Suture Stem Cells: Distributions, Characteristics, and Applications A Study on the Role of miR-126 in the Repair Process after Spinal Cord Injury Magnesium Regulates the Migration and Differentiation of NPMSCs via the Integrin Signaling Pathway Salvianolic Acid B Accelerates Osteoporotic Fracture Healing via LncRNA-MALAT1/miR-155-5p/HIF1A Axis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1